Abstract: A pharmaceutical composition for preventing or treating female climacteric syndromes comprising Loganin which increases the concentration of estradiol (17?-estradiol, E2) in the blood of a menopausal mouse model and has shown efficacies such as an increase in the estrogen receptor alpha expression in the uterus, which remedies uterine contraction and degeneration, and decreases in the accumulation and the size of adipocytes in liver and the abdominal adipose tissues and the liver and weight loss, a derivative thereof or a pharmaceutically acceptable salt thereof as an active ingredient.

Abstract: A display device includes a display panel including first to fourth panel pads and a connection board including first to fourth connection board pads coupled to the first to fourth pads, respectively. The first and second panel pads are electrically connected to each other, and the third and fourth panel pads are electrically connected to each other. The connection board includes a driving circuit which generates a first test result signal based on a first panel test signal transmitted to the first connection board pad and a first panel feedback signal received from the second connection board pad, generates a second test result signal based on a second panel test signal transmitted to the third connection board pad and a second panel feedback signal received from the fourth connection board pad, and sequentially outputs the first and second test result signals as a test result signal.

Abstract: A gate driver includes a gate signal generating part, a switching part and a switching controlling part. The gate signal generating part is configured to generate a gate signal including a precharge time and a normal charge time using a compensated gate on voltage and a gate off voltage. The switching part is disposed between the gate signal generating part and a gate line. The switching part is configured to apply a compensated gate signal to the gate line. The switching controlling part is configured to generate a switching control signal for controlling an operation of the switching part.

Abstract: A display device includes a display panel, and a first flexible printed circuit board bonded to a side surface of the display panel. The display panel includes: a first substrate; a first extension wire on a top surface of the first substrate, the top surface being parallel to a first direction and a second direction, the second direction being perpendicular to the first direction; a first recess portion at a side surface of the first substrate; and a first pad that extends from the first extension wire in a third direction perpendicular to the first and second directions, the first pad being disposed in the recess portion, and the first extension wire and the first pad comprise the same material.

Abstract: A display device includes a display panel including first to fourth panel pads and a connection board including first to fourth connection board pads coupled to the first to fourth pads, respectively. The first and second panel pads are electrically connected to each other, and the third and fourth panel pads are electrically connected to each other. The connection board includes a driving circuit which generates a first test result signal based on a first panel test signal transmitted to the first connection board pad and a first panel feedback signal received from the second connection board pad, generates a second test result signal based on a second panel test signal transmitted to the third connection board pad and a second panel feedback signal received from the fourth connection board pad, and sequentially outputs the first and second test result signals as a test result signal.

Abstract: A method of fabricating a display device includes: providing on a first jig a display panel to which is attached one side of a connection circuit board; providing a main circuit board on a second jig; supporting the connection circuit board with a supporter between the first jig and the second jig; and attaching another side of the connection circuit board to the main circuit board, wherein the supporter includes a base part and a plurality of guides on the base part, the guides being adjusted in length in an up-and-down direction.

Abstract: The present invention relates to a pharmaceutical composition for preventing or treating inflammatory disease, which contains, as an active ingredient, a Bacillus amyloliquefaciens GF423 strain, a superoxide dismutase high-producing Bacillus amyloliquefaciens GF424 mutant strain, a superoxide dismutase (SOD) derived from one of these strains, or both the strain and the SOD. The superoxide dismutase derived from the Bacillus amyloliquefaciens GF423 strain (KCTC 13222BP), which is the active ingredient of the present invention, effectively suppresses or degrades reactive oxygen species, and thus has the effect of fundamentally preventing the causes of inflammatory bowel disease caused by reactive oxygen species. Therefore, the composition of the present invention may be developed into various products, including excellent drugs and health functional foods for preventing or treating inflammatory bowel disease.

Abstract: The present invention relates to a Bacillus amyloliquefaciens strain that produces superoxide dismutase (SOD), and also relates to an antioxidant, anti-inflammatory pharmaceutical composition and a pharmaceutical composition and food composition for preventing or treating hyperlipidemia, which include a superoxide dismutase produced by the Bacillus amyloliquefaciens strain. The compositions of the present invention exhibit excellent effects without causing side effects, and may thus be used as functional raw materials or products having an enhanced activity of preventing or treating inflammation, cancer or hyperlipidemia in the pharmaceutical drug, food, cosmetic and livestock fields.

Abstract: A bio-based N-acetyl-L-methionine and a preparation method thereof, a feed additive containing the N-acetyl-L-methionine, a feed composition containing the feed additive, and a method for raising animals which includes feeding a feed additive containing the N-acetyl-L-methionine or a feed composition containing the feed additive to animals.

Abstract: A display apparatus includes a gate driving control circuit, a gate driver and a display panel. The gate driving control circuit generates N gate clock signals and N inversion gate clock signals based on N gate clock control signals, phases of which partially overlap with each other. Each inversion gate clock signals has an opposite phase to a respective gate clock signal. The gate driver generates gate signals based on the N gate clock signals or the N inversion gate clock signals and applies the gate signals to gate lines. The display panel includes pixels, each connected to a respective gate line and a respective data line. Each of the pixels has a longer side in parallel with gate lines and a shorter side in parallel with the data lines. A number of the gate clock control signals is an integer multiple of a number of colors of the pixels.

Abstract: A gate driver includes a gate signal generating part, a switching part and a switching controlling part. The gate signal generating part is configured to generate a gate signal including a precharge time and a normal charge time using a compensated gate on voltage and a gate off voltage. The switching part is disposed between the gate signal generating part and a gate line. The switching part is configured to apply a compensated gate signal to the gate line. The switching controlling part is configured to generate a switching control signal for controlling an operation of the switching part.

Abstract: A gate driver includes a gate signal generating part, a switching part and a switching controlling part. The gate signal generating part is configured to generate a gate signal including a precharge time and a normal charge time using a compensated gate on voltage and a gate off voltage. The switching part is disposed between the gate signal generating part and a gate line. The switching part is configured to apply a compensated gate signal to the gate line. The switching controlling part is configured to generate a switching control signal for controlling an operation of the switching part.

Abstract: The present invention relates to a Bacillus amyloliquefaciens strain that produces superoxide dismutase (SOD), and also relates to an antioxidant, anti-inflammatory pharmaceutical composition and a pharmaceutical composition and food composition for preventing or treating hyperlipidemia, which include a superoxide dismutase produced by the Bacillus amyloliquefaciens strain. The compositions of the present invention exhibit excellent effects without causing side effects, and may thus be used as functional raw materials or products having an enhanced activity of preventing or treating inflammation, cancer or hyperlipidemia in the pharmaceutical drug, food, cosmetic and livestock fields.

Abstract: A method of operating a display device includes: receiving image data at an input frame frequency; generating a modulated clock signal by modulating an input clock signal according to a modulation frequency; randomly selecting an output frame frequency within a data frequency selection range, the input frame frequency being within the data frequency selection range; determining an output start timing of the image data based on the output frame frequency; initiating, at the output start timing, output of the image data in synchronization with the modulated clock signal; and displaying an image based on the outputted image data.

Abstract: Provided is a pharmaceutical composition for preventing, improving, or treating postmenopausal osteoporosis in women, the composition including, as an active ingredient, scopolin, a derivative thereof, or a pharmaceutically acceptable salt thereof, wherein scopolin has good efficacy in stimulating osteoblast differentiation, and is also effective in inhibiting a reduction in bone density after menopause, low density in a bone microstructure, a reduction in a bone formation marker in the blood, and an increase in a bone resorption marker. Therefore, scopolin and the composition including the same as an active ingredient are expected to be useful as pharmaceutical preparations for the prevention, improvement, or treatment of postmenopausal osteoporosis in women.

Abstract: A learning situation determining method and apparatus is disclosed. The learning situation determining method includes collecting psychophysiological response information of a learner on a first learning image, collecting stimulated recall response information of the learner based on a stimulated recall of the learner in response to a second learning image including a same learning content as the first learning image, determining cognitive load in the leaner that is recalled in each learning interval of the second learning image based on the psychophysiological response information and the stimulated recall response information. Alternatively, the learning situation determining method includes determining cognitive load in a learner learning a learning image for each learning interval of the learning image using psychophysiological response information of the learner based on prior knowledge possessed by the learner and task complexity of the learning image.

Abstract: A gate driver includes a first shift-register including a plurality of odd-numbered stages which outputs a plurality of odd-numbered original gate signals having a pre-charge pulse and a main-charge pulse in synchronization with a first gate clock signal, a second shift-register comprising a plurality of even-numbered stages which outputs a plurality of even-numbered original gate signals having a pre-charge pulse and a main-charge pulse in synchronization with a second gate clock signal, a first inverter configured to output a first inversion pre-charge control signal having a phase opposite to a phase of a first pre-charge control signal, and a second inverter configured to output a second inversion pre-charge control signal having a phase opposite to a phase of a second pre-charge control signal.

Abstract: A pharmaceutical composition for preventing or treating female climacteric syndromes comprising Loganin which increases the concentration of estradiol (17?-estradiol, E2) in the blood of a menopausal mouse model and has shown efficacies such as an increase in the estrogen receptor alpha expression in the uterus, which remedies uterine contraction and degeneration, and decreases in the accumulation and the size of adipocytes in liver and the abdominal adipose tissues and the liver and weight loss, a derivative thereof or a pharmaceutically acceptable salt thereof as an active ingredient.

Abstract: A bio-based N-acetyl-L-methionine and a preparation method thereof, a feed additive containing the N-acetyl-L-methionine, a feed composition containing the feed additive, and a method for raising animals which includes feeding a feed additive containing the N-acetyl-L-methionine or a feed composition containing the feed additive to animals.

Abstract: The present disclosure relates to the preparation of a useful compound, which can be used as an intermediate for preparing an important compound in the industrial field from a homoserine-based compound, and provides a process for treating a homoserine-based compound, capable of mass-producing a useful compound from a homoserine-based compound in a simple manner with excellent efficiency.